Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer

Chandra Belani, Sakkaraiappan Ramalingam

Research output: Contribution to journalEditorial

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)267-268
Number of pages2
JournalClinical Lung Cancer
Volume6
Issue number5
StatePublished - Mar 1 2005

Fingerprint

Carboplatin
Survival Analysis
Paclitaxel
Non-Small Cell Lung Carcinoma
Antineoplastic Agents
Lung Neoplasms
Randomized Controlled Trials
Monoclonal Antibodies
Survival
Bevacizumab

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

@article{434a347152c74d5bbf45739d0d2668ca,
title = "Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer",
author = "Chandra Belani and Sakkaraiappan Ramalingam",
year = "2005",
month = "3",
day = "1",
language = "English (US)",
volume = "6",
pages = "267--268",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "5",

}

Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer. / Belani, Chandra; Ramalingam, Sakkaraiappan.

In: Clinical Lung Cancer, Vol. 6, No. 5, 01.03.2005, p. 267-268.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer

AU - Belani, Chandra

AU - Ramalingam, Sakkaraiappan

PY - 2005/3/1

Y1 - 2005/3/1

UR - http://www.scopus.com/inward/record.url?scp=20744451420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20744451420&partnerID=8YFLogxK

M3 - Editorial

C2 - 15845175

AN - SCOPUS:20744451420

VL - 6

SP - 267

EP - 268

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 5

ER -